Stay updated on I-SPY Trial: Personalized Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the I-SPY Trial: Personalized Breast Cancer Clinical Trial page.

Latest updates to the I-SPY Trial: Personalized Breast Cancer Clinical Trial page
- Check4 days agoChange DetectedA new publication citation has been added to the Publications section, listing authors and the JAMA Oncol article on Cemiplimab and Fianlimab with neoadjuvant chemotherapy in early-stage high-risk ERBB2-negative breast cancer (I-SPY2). This update expands the study's referenced literature and documents ongoing dissemination of trial findings.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, representing a new page build. It does not change the displayed information or user experience.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, reflecting a new deployment/version of the page.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision tag on the page updated from v3.6.0 to v3.6.2, indicating a newer build of the ClinicalTrials.gov page. No substantive content changes are indicated by this revision.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded navigation/help items (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment header formatting. The Revision badge was changed from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision: v3.5.5 replaces the previous v3.5.4, indicating a minor update to the documentation/build.SummaryDifference0.0%

Stay in the know with updates to I-SPY Trial: Personalized Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the I-SPY Trial: Personalized Breast Cancer Clinical Trial page.